The impact of herpes zoster and subsequent chronic pain on patients' daily lives

Journal of Public Health

Volumn 18, Issue 6, 2010, Pages 567-574

  Arnould, Benoit ^a   Benmedjahed, Khadra ^a   Gallais, Jean Luc ^b   Giniès, Patrick ^c   Baron, Ralf ^d  

^a MAPI VALUES   (United States)

^b Medical Practice   (France)

^c HÔPITAL SAINT ELOI   (France)

^d University Hospital   (Germany)

Author keywords

Conceptual model; Herpes zoster; Pain; Patient reported outcomes; Post herpetic neuralgia; Quality of life

Indexed keywords

ARTICLE; BIOMEDICINE; CHRONIC PAIN; DAILY LIFE ACTIVITY; HEALTH STATUS; HERPES ZOSTER; HUMAN; POSTHERPETIC NEURALGIA; QUALITY OF LIFE;

EID: 78649957947     PISSN: 09431853     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10389-010-0346-6     Document Type: Article

References (58)

1. C Acquadro R Berzon D Dubois NK Leidy P Marquis D Revicki M Rothman 2003 Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001 Value Health 6 522 531 10.1046/j.1524-4733.2003.65309.x 14627058 (Pubitemid 37187713)
2. A Binder J Koroschetz R Baron 2008 Disease mechanisms in neuropathic itch Nat Clin Pract Neurol 4 329 337 10.1038/ncpneuro0806 18461071 (Pubitemid 351803615)
3. D Bowsher 1999 The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population Eur J Pain 3 335 342 10.1016/S1090-3801(99)90015-0 10700361
4. M Brisson WJ Edmunds 2003 Epidemiology of varicella-zoster virus in England and Wales J Med Virol 70 Suppl 1 S9 S14 10.1002/jmv.10313 12627480 (Pubitemid 36368838)
5. RS Chapman KW Cross DM Fleming 2003 The incidence of shingles and its implications for vaccination policy Vaccine 21 2541 2547 10.1016/S0264-410X(03) 00034-3 12744889 (Pubitemid 36561347)
6. O Chassany P Sagnier P Marquis S Fullerton N Aaronson 2002 Patient-reported outcomes: the example of health-related quality of life-a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process Drug Inf J 36 209 238
7. C Chidiac J Bruxelle JP Daures T Hoang-Xuan P Morel A Leplege A El Hasnaoui C de Labareyte 2001 Characteristics of patients with herpes zoster on presentation to practitioners in France Clin Infect Dis 33 62 69 1:STN:280:DC%2BD3Mzhs1egtQ%3D%3D 10.1086/320884 11389496 (Pubitemid 32554504)
8. Clark MR, Heinberg LJ, Haythornthwaite JA, Quatrano-Piacentini AL, Pappagallo M, Raja SN (2000) Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease. J Psychosom Res 48:51-57
9. Committee for Medicinal Products for Human Use, CHMP (2007) Guideline on clinical medicinal products intended for the treatment of neuropathic pain. Accessed 16 December 2009
10. PM Coplan K Schmader A Nikas IS Chan P Choo MJ Levin G Johnson M Bauer HM Williams KM Kaplan HA Guess MN Oxman 2004 Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory J Pain 5 344 356 10.1016/j.jpain.2004.06.001 15336639 (Pubitemid 39164674)
11. AL Cunningham J Breuer DE Dwyer DW Gronow RD Helme JC Litt MJ Levin CR Macintyre 2008 The prevention and management of herpes zoster Med J Aust 188 171 176 18241179
12. Dworkin RH, Hartstein G, Rosner HL, Walther RR, Sweeney EW, Brand L (1992) A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol 101:200-205
13. RH Dworkin RW Johnson J Breuer JW Gnann MJ Levin M Backonja RF Betts AA Gershon ML Haanpaa MW McKendrick TJ Nurmikko AL Oaklander MN Oxman D Pavan-Langston KL Petersen MC Rowbotham KE Schmader BR Stacey SK Tyring AJ van Wijck MS Wallace SW Wassilew RJ Whitley 2007 Recommendations for the management of herpes zoster Clin Infect Dis 44 Suppl 1 S1 S26 1:CAS:528: DC%2BD2sXmt12gsA%3D%3D 10.1086/510206 17143845 (Pubitemid 44956795)
14. DE Dwyer AL Cunningham 2002 10: herpes simplex and varicella-zoster virus infections Med J Aust 177 267 273 12197826
15. Farrell MJ, Gerontol M, Gibson SJ, Helme RD (1995) The effect of medical status on the activity level of older pain clinic patients. J Am Geriatr Soc 43:102-107
16. HL Fields M Rowbotham R Baron 1998 Postherpetic neuralgia: irritable nociceptors and deafferentation Neurobiol Dis 5 209 227 1:CAS:528: DyaK1cXnsFGntbk%3D 10.1006/nbdi.1998.0204 9848092 (Pubitemid 28519152)
17. Gauthier A, Breuer J, Carrington D, Martin M, Remy V (2008) Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 1-10
18. Giannakouris K (2008) Ageing characterises the demographic perspectives of the European societies. Accessed 16 December 2009
19. JW Gnann Jr 2008 Vaccination to prevent herpes zoster in older adults J Pain 9 S31 S36 1:CAS:528:DC%2BD1cXhtlSmsw%3D%3D 10.1016/j.jpain.2007.10.007 18166463 (Pubitemid 350309524)
20. CL Goh L Khoo 1997 A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic Int J Dermatol 36 667 672 1:STN:280:DyaK1c%2FhtlKrtg%3D%3D 10.1046/j.1365-4362. 1997.00241.x 9352407
21. Haythornthwaite JA, Clark MR, Pappagallo M, Raja SN (2003) Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia. Pain 106:453-460
22. RE Hope-Simpson 1965 The nature of herpes zoster: a long-term study and a new hypothesis Proc R Soc Med 58 9 20 1:STN:280:DyaF2M%2Fnt1Smuw%3D%3D 14267505
23. RW Johnson 1995 The future of predictors, prevention, and therapy in postherpetic neuralgia Neurology 45 S70 S72 1:STN:280:DyaK287js1agsw%3D%3D 8545029
24. R Johnson 2001 Herpes zoster-predicting and minimizing the impact of post-herpetic neuralgia J Antimicrob Chemother 47 Suppl T1 1 8 1:CAS:528:DC%2BD3MXhtlGntLY%3D 10.1093/jac/47.suppl-1.1 11160029
25. RW Johnson 2004 Pain following herpes zoster: implications for management Herpes 11 3 63 65 15960902
26. RW Johnson AS Rice 2007 Pain following herpes zoster: the influence of changing population characteristics and medical developments Pain 128 3 5 10.1016/j.pain.2006.10.024 17161531 (Pubitemid 46216612)
27. RW Johnson G Wasner P Saddier R Baron 2007 Postherpetic neuralgia: epidemiology, pathophysiology and management Expert Rev Neurother 7 1581 1595 1:CAS:528:DC%2BD2sXht1ynurbM 10.1586/14737175.7.11.1581 17997705 (Pubitemid 350106836)
28. RW Johnson G Wasner P Saddier R Baron 2008 Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient Drugs Aging 25 991 1006 1:CAS:528:DC%2BD1MXhsV2mtLc%3D 10.2165/0002512-200825120-00002 19021299
29. J Katz EM Cooper RR Walther EW Sweeney RH Dworkin 2004 Acute pain in herpes zoster and its impact on health-related quality of life Clin Infect Dis 39 342 348 10.1086/421942 15307000 (Pubitemid 39050481)
30. Katz J, McDermott MP, Cooper EM, Walther RR, Sweeney EW, Dworkin RH (2005) Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster. J Pain 6:782-790
31. E Lydick RS Epstein D Himmelberger CJ White 1995 Area under the curve: a metric for patient subjective responses in episodic diseases Qual Life Res 4 41 45 1:STN:280:DyaK2M3islWgsQ%3D%3D 10.1007/BF00434382 7711690
32. P Marquis B Arnould C Acquadro WM Roberts 2006 Patient-reported outcomes and health-related quality of life in effectiveness studies: pros and cons Drug Dev Res 67 193 201 1:CAS:528:DC%2BD28Xnt1OlsLg%3D 10.1002/ddr.20077 (Pubitemid 44099979)
33. J Mauskopf R Austin L Dix R Berzon 1994 The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity Qual Life Res 3 431 435 1:STN:280:DyaK2M7ntVKqsg%3D%3D 10.1007/BF00435395 7866361
34. Meyer-Rosberg K, Burckhardt CS, Huizar K, Kvarnstrom A, Nordfors LO, Kristofferson A (2001) A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur J Pain 5:391-403
35. E Miller R Marshall J Vurdien 1993 Epidemiology, outcome and control of varicella-zoster infection Rev Med Micro-biol 4 222 230
36. L Neumann A Berzak D Buskila 2000 Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36) Semin Arthritis Rheum 29 400 408 1:STN:280:DC%2BD3M%2FktVOrsQ%3D%3D 10.1053/sarh.2000.7171 10924026
37. Oster G, Dukes E, Edelsberg J, Cleary P (2004) Relationship between pain and perceived health status in older persons with post-herpetic neuralgia. International Society for Pharmacoeconomics and Outcomes Research; 9th Annual International Meeting. Arlington, VA. Value in Health.
38. Oxman MN (2000) Clinical manifestations of herpes zoster. In: Arvin A, Gershon AA (eds) Varicella-zoster virus. Virology and clinical management. Cambridge University Press, Cambridge, pp 246-275
39. MN Oxman MJ Levin 2008 Vaccination against herpes zoster and postherpetic neuralgia J Infect Dis 197 Suppl 2 S228 S236 10.1086/522159 18419402 (Pubitemid 351590176)
40. MN Oxman MJ Levin GR Johnson KE Schmader SE Straus LD Gelb RD Arbeit MS Simberkoff AA Gershon LE Davis A Weinberg KD Boardman HM Williams JH Zhang PN Peduzzi CE Beisel VA Morrison JC Guatelli PA Brooks CA Kauffman CT Pachucki KM Neuzil RF Betts PF Wright MR Griffin P Brunell NE Soto AR Marques SK Keay RP Goodman DJ Cotton JW Gnann Jr J Loutit M Holodniy WA Keitel GE Crawford SS Yeh Z Lobo JF Toney RN Greenberg PM Keller R Harbecke AR Hayward MR Irwin TC Kyriakides CY Chan IS Chan WW Wang PW Annunziato JL Silber 2005 A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2271 2284 1:CAS:528:DC%2BD2MXksl2ltro%3D 10.1056/NEJMoa051016 15930418 (Pubitemid 40740551)
41. DL Patrick LB Burke JH Powers JA Scott EP Rock S Dawisha R O'Neill DL Kennedy 2007 Patient-reported outcomes to support medical product labeling claims: FDA perspective Value Health 10 Suppl 2 S125 S137 10.1111/j.1524-4733. 2007.00275.x 17995471 (Pubitemid 350098929)
42. MC Rowbotham KL Petersen 2001 Zoster-associated pain and neural dysfunction Pain 93 1 5 1:STN:280:DC%2BD3MzktlClsQ%3D%3D 10.1016/S0304-3959(01) 00328-1 11406332 (Pubitemid 32530836)
43. H Schipper 1990 Guidelines and caveats for quality of life measurement in clinical practice and research Oncology (Williston Park) 4 51 57 1:STN:280:DyaK3czksVGhtQ%3D%3D
44. K Schmader 1999 Herpes zoster in the elderly: issues related to geriatrics Clin Infect Dis 28 736 739 1:STN:280:DC%2BD3c3otlWktA%3D%3D 10.1086/515205 10825029
45. K Schmader 2001 Herpes zoster in older adults Clin Infect Dis 32 1481 1486 1:STN:280:DC%2BD3MzivVWktw%3D%3D 10.1086/320169 11317250 (Pubitemid 32424284)
46. K Schmader RH Dworkin 2008 Natural history and treatment of herpes zoster J Pain 9 S3 S9 1:CAS:528:DC%2BD1cXhtlSmsg%3D%3D 10.1016/j.jpain.2007.10.002 18166460
47. Schmader K, George LK, Burchett BM, Pieper CF (1998) Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis 178(Suppl 1):S67-S70
48. Schmader K, Studenski S, MacMillan J, Grufferman S, Cohen HJ (1990) Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc 38:1188-1194
49. KE Schmader R Sloane C Pieper PM Coplan A Nikas P Saddier IS Chan P Choo MJ Levin G Johnson HM Williams MN Oxman 2007 The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults Clin J Pain 23 490 496 10.1097/AJP.0b013e318065b6c9 17575488 (Pubitemid 46956185)
50. FT Scott RW Johnson M Leedham-Green E Davies WJ Edmunds J Breuer 2006 The burden of herpes zoster: a prospective population based study Vaccine 24 1308 1314 10.1016/j.vaccine.2005.09.026 16352376 (Pubitemid 43222038)
51. Spilker B (1990) Introduction to the field of quality of life trials. In: Spilker B (ed) Quality of life assessments in clinical trials. Raven Press, New York, pp 3-10
52. Sullivan MJ, Lynch ME, Clark AJ (2005) Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions. Pain 113:310-315
53. R van Seventer A Sadosky M Lucero E Dukes 2006 A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia Age Ageing 35 132 137 10.1093/ageing/afj048 16431855
54. TR Vetter 2007 A primer on health-related quality of life in chronic pain medicine Anesth Analg 104 703 718 1:CAS:528:DC%2BD2sXhvFWrt70%3D 10.1213/01.ane.0000255290.64837.61 17312232
55. DW Wareham J Breuer 2007 Herpes zoster BMJ 334 1211 1215 10.1136/bmj.39206.571042.AE 17556477 (Pubitemid 46954586)
56. IB Wilson PD Cleary 1995 Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes JAMA 273 59 65 1:STN:280:DyaK2M%2FovFWgtA%3D%3D 10.1001/jama.273.1.59 7996652
57. F Wolfe DJ Hawley 1997 Measurement of the quality of life in rheumatic disorders using the EuroQol Br J Rheumatol 36 786 793 1:STN:280: DyaK2szpvV2rtA%3D%3D 10.1093/rheumatology/36.7.786 9255115
58. CL Wu SN Raja 2008 An update on the treatment of postherpetic neuralgia J Pain 9 S19 S30 1:CAS:528:DC%2BD1cXhtlSnuw%3D%3D 10.1016/j.jpain.2007.10.006 18166462 (Pubitemid 350309523)